iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by iBio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for iBio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Carr Molly | Chief Medical Officer | – | Aug 4, 2026 | 1 |
| Stoner Elizabeth | Director | – | May 19, 2026 | 1 |
| Banjak Marc | Chief Legal Officer | 25,000 | Mar 27, 2026 | 3 |
| Brenner Martin | See Remarks | 30,652 | Mar 23, 2026 | 3 |
| Duran Felipe | Chief Financial Officer | 35,974 | Mar 23, 2026 | 3 |
| Arkowitz David | Director | 18,382 | Nov 24, 2025 | 1 |
| Clark William D | Director | 1,838 | Nov 24, 2025 | 1 |
| Sender Gary | Director | 9,191 | Nov 24, 2025 | 1 |
| Schimmelpennink Evert B. | Director | – | Nov 24, 2025 | 1 |
| Kropotova Alexandra | Director | – | Nov 24, 2025 | 1 |
| Parada Antonio Bernardino Guimaraes | Director | 183,823Indirect | Nov 24, 2025 | 1 |
| Lutz Robert Matthew | See Remarks | 102,165 | Nov 15, 2022 | 0 |
| Isett Thomas Francis 3rd | CEO and Executive Chairman | – | Sep 12, 2022 | 0 |
| Maddux Randy Joe | Chief Operating Officer | 271,757 | Mar 14, 2022 | 0 |
| McKey John D Jr | Director | – | Dec 13, 2021 | 0 |
| Chang Glenn | Director | – | Dec 13, 2021 | 0 |
| GENERAL HILL (Ret) JAMES T. | Director | – | Dec 13, 2021 | 0 |
| Armstrong Linda Washington | Director | – | Dec 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 (view filing) | Mar 26 | 1 day | Banjak MarcChief Legal Officer | PPurchase | +13.9K | $1.65 | +$23.0K | +125.9%25.0K after | 2 lots |
| Mar 23, 2026 (view filing) | Mar 19 | 4 days | Duran FelipeChief Financial Officer | PPurchase | +24.8K | $2.02 | +$50.2K | +223.0%36.0K after | |
| Mar 23, 2026 (view filing) | Mar 19 | 4 days | Brenner MartinSee Remarks | PPurchase | +12.3K | $2.02 | +$24.9K | +67.4%30.7K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Duran FelipeChief Financial Officer | PPurchase | +9.19K | $2.72 | +$25.0K | +471.8%11.1K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Brenner MartinSee Remarks | PPurchase | +9.19K | $2.72 | +$25.0K | +100.7%18.3K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Banjak MarcChief Legal Officer | PPurchase | +9.19K | $2.72 | +$25.0K | +490.2%11.1K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Arkowitz DavidDirector | PPurchase | +18.4K | $2.72 | +$50.0K | New position18.4K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Clark William DDirector | PPurchase | +1.84K | $2.72 | +$5.00K | New position1.84K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Parada Antonio Bernardino GuimaraesDirector | PPurchase | +183.8K | $2.72 | +$500.0K | New position183.8K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Sender GaryDirector | PPurchase | +9.19K | $2.72 | +$25.0K | New position9.19K after | |
| Nov 3, 2023 (view filing)4:01 PM ET | Nov 1 | 2 days | Brenner MartinSee Remarks | SSale | −4.88K | $0.2655 | −$1.30K | −2.6%182.5K after | |
| Oct 5, 2023 (view filing)4:01 PM ET | Oct 3 | 2 days | Brenner MartinSee Remarks | SSale | −5.27K | $0.3022 | −$1.59K | −2.7%187.4K after | |
| Oct 3, 2023 (view filing)4:01 PM ET | Oct 2 | 1 day | Brenner MartinSee Remarks | SSale | −4.21K | $0.311 | −$1.31K | −2.1%192.7K after | |
| Aug 30, 2023 (view filing)4:22 PM ET | Aug 28 | 2 days | Brenner MartinSee Remarks | SSale | −5.01K | $0.3051 | −$1.53K | −2.5%196.9K after | |
| Jul 28, 2023 (view filing) | Jul 27 | 1 day | Brenner MartinSee Remarks | SSale | −4.51K | $0.51 | −$2.30K | −2.2%201.9K after | 2 lots |
| Jul 13, 2023 (view filing) | Jul 12 | 1 day | Brenner MartinSee Remarks | SSale | −47.0K | $0.59 | −$27.7K | −18.6%206.4K after | |
| Jun 22, 2023 (view filing) | Jun 21 | 1 day | Brenner MartinSee Remarks | SSale | −4.18K | $0.6805 | −$2.85K | −1.6%253.4K after | 3 lots |
| May 24, 2023 (view filing) | May 22 | 2 days | Brenner MartinSee Remarks | SSale | −4.18K | $0.9401 | −$3.93K | −1.6%257.6K after | 2 lots |
| Apr 24, 2023 (view filing) | Apr 24 | Same day | Brenner MartinSee Remarks | SSale | −4.38K | $1.20 | −$5.26K | −1.6%261.8K after | |
| Mar 28, 2023 (view filing) | Mar 23 | 5 daysLate | Brenner MartinSee Remarks | SSale | −5.21K | $2.13 | −$11.1K | −2.4%216.2K after | |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Brenner MartinSee Remarks | SSale | −3.98K | $1.77 | −$7.04K | −1.8%221.4K after | |
| Mar 14, 2022 (view filing)4:12 PM ET | Mar 10 | 4 days | Lutz Robert MatthewSee Remarks | SSale | −24.6K | $0.3456 | −$8.51K | −10.6%207.4K after | |
| Mar 14, 2022 (view filing) | Dec 7, 2021 | 97 daysLate | Maddux Randy JoeChief Operating Officer | SSale | −37.2K | $0.68 | −$25.3K | −12.1%271.8K after |